Oxytocin in schizophrenia: A review of evidence for its therapeutic effects

Acta Neuropsychiatrica

Volumn 24, Issue 3, 2012, Pages 130-146

  MacDonald, Kai ^a   Feifel, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

brain physiology; double blind method; humans; intranasal; oxytocin administration and dosage; schizophrenia; social perception

Indexed keywords

AMPEROZIDE; AMPHETAMINE; ATOSIBAN; CARBETOCIN; CLOZAPINE; COCAINE; DIZOCILPINE; HALOPERIDOL; NEUROPHYSIN; OLANZAPINE; OXYTOCIN; OXYTOCIN RECEPTOR; PIMOZIDE; PLACEBO; RISPERIDONE; VASOPRESSIN;

AMNESIA; AMYGDALOID NUCLEUS; CEREBROSPINAL FLUID; CLINICAL GLOBAL IMPRESSION SCALE; DISEASE ASSOCIATION; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG MECHANISM; HUMAN; HYPONATREMIA; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MENTAL DISEASE; NEUROBIOLOGY; NEUROIMAGING; NEUROPATHOLOGY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PARANOIA; POLYDIPSIA; POSITIVE AND NEGATIVE SYNDROME SCALE; PREPULSE INHIBITION; REVIEW; SCHIZOPHRENIA; SOCIAL COGNITION; SUBSTANTIA NIGRA; THEORY OF MIND; VERBAL MEMORY;

EID: 84861633595     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2011.00634.x     Document Type: Review

References (201)

1. Van Os J, Kapur S., Schizophrenia. Lancet 2009; 374: 635-645.
2. Keshavan MS, Nasrallah HA, Tandon R., Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse. Schizophr Res 2011; 127: 3-13.
3. Meyer-Lindenberg A., From maps to mechanisms through neuroimaging of schizophrenia. Nature 2010; 468: 194-202.
4. Guo X, Zhai J, Liu Z, et al., Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: a randomized, 1-year study. Arch Gen Psychiatry 2010; 67: 895-904.
5. Leucht C, Heres S, Kane JM, Kissling W, Davis JM, Leucht S., Oral versus depot antipsychotic drugs for schizophrenia -a critical systematic review and meta-analysis of randomised long-term trials. Schizophr Res 2011; 127: 83-92.
6. Agid O, Mamo D, Ginovart N, et al., Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response -a double-blind PET study in schizophrenia. Neuropsychopharmacology 2007; 32: 1209-1215. (Pubitemid 46788848)
7. Dziedzicka-Wasylewska M, Faron-Gorecka A, Gorecki A, Kusemider M., Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization -a working hypothesis. Pharmacol Rep 2008; 60: 581-587.
8. Nord M, Farde L., Antipsychotic occupancy of dopamine receptors in schizophrenia. CNS Neurosci Ther 2011; 17: 97-103.
9. Bujanow W., Hormones in the treatment of psychoses. Br Med J 1972; 4: 298.
10. Kimura T, Tanizawa O, Mori K, Brownstein MJ, Okayama H., Structure and expression of a human oxytocin receptor. Nature 1992; 356: 526-529.
11. Ivell R, Richter D., Structure and comparison of the oxytocin and vasopressin genes from rat. Proc Natl Acad Sci U S A 1984; 81: 2006-2010. (Pubitemid 14146595)
12. Feifel D, Macdonald K, Nguyen A, et al., Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry 2010; 68: 678-680.
13. Pedersen CA, Gibson CM, Rau SW, et al., Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophr Res 2011; 132: 50-53.
14. Donaldson ZR, Young LJ., Oxytocin, vasopressin, and the neurogenetics of sociality. Science 2008; 322: 900-904.
15. Gimpl G, Fahrenholz F., The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001; 81: 629-683. (Pubitemid 32267075)
16. Madden JR, Clutton-Brock TH., Experimental peripheral administration of oxytocin elevates a suite of cooperative behaviours in a wild social mammal. Proc Biol Sci 2011; 278: 1189-1194.
17. Goodson JL, Schrock SE, Klatt JD, Kabelik D, Kingsbury MA., Mesotocin and nonapeptide receptors promote estrildid flocking behavior. Science 2009; 325: 862-866.
18. Oldfield RG, Hofmann HA., Neuropeptide regulation of social behavior in a monogamous cichlid fish. Physiol Behav 2011; 102: 296-303.
19. Wagenaar DA, Hamilton MS, Huang T, Kristan WB, French KA., A hormone-activated central pattern generator for courtship. Curr Biol 2010; 20: 487-495.
20. Sala M, Braida D, Lentini D, et al., Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol Psychiatry 2011; 69: 875-882.
21. Schorscher-Petcu A, Sotocinal S, Ciura S, et al., Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse. J Neurosci, 2010; 30: 8274-8284.
22. Seifer DB, Sandberg EC, Ueland K, Sladen RN., Water intoxication and hyponatremic encephalopathy from the use of an oxytocin nasal spray. A case report. J Reprod Med 1985; 30: 225-228. (Pubitemid 15090387)
23. Stratton JF, Stronge J, Boylan PC., Hyponatraemia and non-electrolyte solutions in labouring primigravida. Eur J Obstet Gynecol Reprod Biol 1995; 59: 149-151.
24. Li C, Wang W, Summer SN, et al., Molecular mechanisms of antidiuretic effect of oxytocin. J Am Soc Nephrol 2008; 19: 225-232. (Pubitemid 351240644)
25. Liggins GC., Antidiuretic effects of oxytocin, morphine and pethidine in pregnancy and labour. Aust N Z J Obstet Gynaecol 1963; 3: 81-83.
26. Carter CS, Grippo AJ, Pournajafi-Nazarloo H, Ruscio MG, Porges SW., Oxytocin, vasopressin and sociality. Prog Brain Res 2008; 170: 331-336. (Pubitemid 352010239)
27. Insel TR., Oxytocin -a neuropeptide for affiliation: evidence from behavioral, receptor autoradiographic, and comparative studies. Psychoneuroendocrinology 1992; 17: 3-35.
28. Insel TR., The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 2010; 65: 768-779.
29. Landgraf R, Neumann ID., Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol 2004; 25: 150-176. (Pubitemid 39642188)
30. Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M., Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 2011; 12: 524-538.
31. Sogolow SR., An historical review of the use of oxytocin prior to delivery. Obstet Gynecol Surv 1966; 21: 155-172.
32. Uvnas-Moberg K, Eriksson M., Breastfeeding: physiological, endocrine and behavioural adaptations caused by oxytocin and local neurogenic activity in the nipple and mammary gland. Acta Paediatr 1996; 85: 525-530.
33. Amico JA, Challinor SM, Cameron JL., Pattern of oxytocin concentrations in the plasma and cerebrospinal fluid of lactating rhesus monkeys (Macaca mulatta): evidence for functionally independent oxytocinergic pathways in primates. J Clin Endocrinol Metab 1990; 71: 1531-1535. (Pubitemid 120032771)
34. Amico JA, Tenicela R, Johnston J, Robinson AG., A time-dependent peak of oxytocin exists in cerebrospinal fluid but not in plasma of humans. J Clin Endocrinol Metab 1983; 57: 947-951. (Pubitemid 14204292)
35. Neumann ID., Stimuli and consequences of dendritic release of oxytocin within the brain. Biochem Soc Trans 2007; 35 (Pt 5): 1252-1257. (Pubitemid 350206473)
36. Burri A, Heinrichs M, Schedlowski M, Kruger TH., The acute effects of intranasal oxytocin administration on endocrine and sexual function in males. Psychoneuroendocrinology 2008; 33: 591-600.
37. Feldman R, Gordon I, Schneiderman I, Weisman O, Zagoory-Sharon O., Natural variations in maternal and paternal care are associated with systematic changes in oxytocin following parent-infant contact. Psychoneuroendocrinology 2010; 35: 1133-1141.
38. Light KC, Smith TE, Johns JM, Brownley KA, Hofheimer JA, Amico JA., Oxytocin responsivity in mothers of infants: a preliminary study of relationships with blood pressure during laboratory stress and normal ambulatory activity. Health Psychol 2000; 19: 560-567.
39. Strathearn L, Fonagy P, Amico J, Montague PR., Adult attachment predicts maternal brain and oxytocin response to infant cues. Neuropsychopharmacology 2009; 34: 2655-2666.
40. Veenema AH, Neumann ID., Central vasopressin and oxytocin release: regulation of complex social behaviours. Prog Brain Res 2008; 170: 261-276. (Pubitemid 352010234)
41. Veening JG, de Jong T, Barendregt HP., Oxytocin-messages via the cerebrospinal fluid: behavioral effects; a review. Physiol Behav 2010; 101: 193-210.
42. Goldman M, Marlow-O'Connor M, Torres I, Carter CS., Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Schizophr Res 2008; 98: 247-255. (Pubitemid 350235898)
43. Rubin LH, Carter CS, Drogos L, et al., Sex-specific associations between peripheral oxytocin and emotion perception in schizophrenia. Schizophr Res 2011; 130: 266-270.
44. Rubin LH, Carter CS, Drogos L, Pournajafi- Nazarloo H, Sweeney JA, Maki PM., Peripheral oxytocin is associated with reduced symptom severity in schizophrenia. Schizophr Res 2010; 124: 13-21.
45. Gutkowska J, Jankowski M., Oxytocin revisited: it is also a cardiovascular hormone. J Am Soc Hyperten 2008; 2: 318-325.
46. Feldman R, Gordon I, Zagoory-Sharon O., Maternal and paternal plasma, salivary, and urinary oxytocin and parent-infant synchrony: considering stress and affiliation components of human bonding. Dev Sci 2011; 14: 752-761.
47. Ludwig M, Leng G., Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci 2006; 7: 126-136. (Pubitemid 43151599)
48. Buijs RM, Van Heerikhuize JJ., Vasopressin and oxytocin release in the brain -a synaptic event. Brain Res 1982; 252: 71-76. (Pubitemid 13231465)
49. Sofroniew MV, Weindl A, Schrell U, Wetzstein R., Immunohistochemistry of vasopressin, oxytocin and neurophysin in the hypothalamus and extrahypothalamic regions of the human and primate brain. Acta Histochem Suppl 1981; 24: 79-95.
50. Baumgartner T, Heinrichs M, Vonlanthen A, Fischbacher U, Fehr E., Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 2008; 58: 639-650. (Pubitemid 351672358)
51. Domes G, Heinrichs M, Glascher J, Buchel C, Braus DF, Herpertz SC., Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 2007; 62: 1187-1190. (Pubitemid 350029722)
52. Domes G, Lischke A, Berger C, et al., Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology 2010; 35: 83-93.
53. Gamer M, Zurowski B, Buchel C., Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans. Proc Natl Acad Sci U S A 2010; 107: 9400-9405.
54. Kirsch P, Esslinger C, Chen Q, et al., Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 2005; 25: 11489-11493. (Pubitemid 43083720)
55. Petrovic P, Kalisch R, Singer T, Dolan RJ., Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci 2008; 28: 6607-6615.
56. Riem MM, Bakermans-Kranenburg MJ, Pieper S, et al., Oxytocin modulates amygdala, insula, and inferior frontal gyrus responses to infant crying: a randomized controlled trial. Biol Psychiatry 2011; 70: 291-297.
57. Rilling JK, Demarco AC, Hackett PD, et al., Effects of intranasal oxytocin and vasopressin on cooperative behavior and associated brain activity in men. Psychoneuroendocrinology 2011 (in press).
58. McGregor IS, Callaghan PD, Hunt GE., From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? Br J Pharmacol 2008; 154: 358-368. (Pubitemid 351670596)
59. Rosenfeld AJ, Lieberman JA, Jarskog LF., Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia. Schizophr Bull 2011; 37: 1077-1087.
60. de Bono M., Molecular approaches to aggregation behavior and social attachment. J Neurobiol 2003; 54: 78-92. (Pubitemid 36043669)
61. Skuse DH, Gallagher L., Dopaminergic-neuropeptide interactions in the social brain. Trends Cogn Sci 2009; 13: 27-35.
62. Broad KD, Levy F, Evans G, Kimura T, Keverne EB, Kendrick KM., Previous maternal experience potentiates the effect of parturition on oxytocin receptor mRNA expression in the paraventricular nucleus. Eur J Neurosci 1999; 11: 3725-3737. (Pubitemid 29484268)
63. Loup F, Tribollet E, Dubois-Dauphin M, Dreifuss J J., Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study. Brain Res 1991; 555: 220-232.
64. Loup F, Tribollet E, Dubois-Dauphin M, Pizzolato G, Dreifuss JJ., Localization of oxytocin binding sites in the human brainstem and upper spinal cord: an autoradiographic study. Brain Res 1989; 500: 223-230. (Pubitemid 19257041)
65. Tribollet E, Dubois-Dauphin M, Dreifuss JJ, Barberis C, Jard S., Oxytocin receptors in the central nervous system. Distribution, development, and species differences. Ann N Y Acad Sci 1992; 652: 29-38.
66. Inoue H, Yamasue H, Tochigi M, et al., Association between the oxytocin receptor gene and amygdalar volume in healthy adults. Biol Psychiatry 2011; 68: 1066-1072.
67. Liu X, Kawamura Y, Shimada T, et al., Association of the oxytocin receptor (OXTR) gene polymorphisms with autism spectrum disorder (ASD) in the Japanese population. J Hum Genet 2011; 55: 137-141.
68. Montag C, Fiebach CJ, Kirsch P, Reuter M., Interaction of 5-HTTLPR and a variation on the oxytocin receptor gene influences negative emotionality. Biol Psychiatry 2011; 69: 601-603.
69. Rodrigues SM, Saslow LR, Garcia N, John OP, Keltner D., Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans. Proc Natl Acad Sci U S A 2009; 106: 21437-21441.
70. Thompson RJ, Parker KJ, Hallmayer JF, Waugh CE, Gotlib IH., Oxytocin receptor gene polymorphism (rs225 4298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls. Psychoneuroendocrinology 2011; 36: 144-147.
71. Insel TR., A neurobiological basis of social attachment. Am J Psychiatry 1997; 154: 726-735. (Pubitemid 27230093)
72. Bale TL, Davis AM, Auger AP, Dorsa DM, McCarthy MM., CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J Neurosci 2001; 21: 2546-2552. (Pubitemid 32240551)
73. Meddle SL, Bishop VR, Gkoumassi E, Van Leeuwen FW, Douglas AJ., Dynamic changes in oxytocin receptor expression and activation at parturition in the rat brain. Endocrinology 2007; 148: 5095-5104. (Pubitemid 47481536)
74. Champagne F, Diorio J, Sharma S, Meaney MJ., Naturally occurring variations in maternal behavior in the rat are associated with differences in estrogen-inducible central oxytocin receptors. Proc Natl Acad Sci U S A 2001; 98: 12736-12741. (Pubitemid 33020015)
75. Champagne FA, Chretien P, Stevenson CW, Zhang TY, Gratton A, Meaney MJ., Variations in nucleus accumbens dopamine associated with individual differences in maternal behavior in the rat. J Neurosci 2004; 24: 4113-4123. (Pubitemid 38620786)
76. Norman GJ, Karelina K, Morris JS, Zhang N, Cochran M, Courtney DeVries A., Social interaction prevents the development of depressive-like behavior post nerve injury in mice: a potential role for oxytocin. Psychosom Med 2010; 72: 519-526.
77. Timmer M, Cordero MI, Sevelinges Y, Sandi C., Evidence for a role of oxytocin receptors in the long-term establishment of dominance hierarchies. Neuropsychopharmacology 2011; 36: 2349-2356.
78. Lieberman JA, Sheitman BB, Kinon BJ., Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 1997; 17: 205-229. (Pubitemid 27440642)
79. Pruessner JC, Champagne F, Meaney MJ, Dagher A., Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using raclopride. J Neurosci 2004; 24: 2825-2831. (Pubitemid 38380960)
80. Selten JP, Cantor-Graae E., Social defeat: risk factor for schizophrenia? Br J Psychiatry 2005; 187: 101-102. (Pubitemid 41139679)
81. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL., Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 2002; 5: 514-516. (Pubitemid 34568991)
82. Illum L., Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol 2004; 56: 3-17. (Pubitemid 38195323)
83. Rossoni E, Feng J, Tirozzi B, Brown D, Leng G, Moos F., Emergent synchronous bursting of oxytocin neuronal network. PLoS Comput Biol 2008; 4: e1000123.
84. Mens WB, Witter A, Van Wimersma Greidanus TB., Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF. Brain Res 1983; 262: 143-149. (Pubitemid 13188658)
85. Robinson IC, Coombes JE., Neurohypophysial peptides in cerebrospinal fluid: an update. Ann N Y Acad Sci 1993; 689: 269-284. (Pubitemid 23282419)
86. Robinson IC, Jones PM., Oxytocin and neurophysin in plasma and CSF during suckling in the guinea-pig. Neuroendocrinology 1982; 34: 59-63. (Pubitemid 12197089)
87. Carter CS., Developmental consequences of oxytocin. Physiol Behav 2003; 79: 383-397. (Pubitemid 37087906)
88. Choleris E, Devidze N, Kavaliers M, Pfaff DW., Steroidal/neuropeptide interactions in hypothalamus and amygdala related to social anxiety. Prog Brain Res 2008; 170: 291-303. (Pubitemid 352010236)
89. Patisaul HB, Scordalakes EM, Young LJ, Rissman EF., Oxytocin, but not oxytocin receptor, is regulated by oestrogen receptor beta in the female mouse hypothalamus. J Neuroendocrinol 2003; 15: 787-793. (Pubitemid 36880737)
90. Emiliano AB, Cruz T, Pannoni V, Fudge JL., The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: a substrate for SSRIs therapeutic effects? Neuropsychopharmacology 2007; 32: 977-988. (Pubitemid 46631974)
91. Baskerville TA, Douglas AJ., Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders. CNS Neurosci Ther 2010; 16: e92-e123.
92. Shahrokh DK, Zhang TY, Diorio J, Gratton A, Meaney MJ., Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat. Endocrinology 2010; 151: 2276-2286.
93. Succu S, Sanna F, Melis T, Boi A, Argiolas A, Melis MR., Stimulation of dopamine receptors in the paraventricular nucleus of the hypothalamus of male rats induces penile erection and increases extra-cellular dopamine in the nucleus accumbens: involvement of central oxytocin. Neuropharmacology 2007; 52: 1034-1043. (Pubitemid 46227490)
94. Hrabovszky E, Liposits Z., Novel aspects of glutamatergic signalling in the neuroendocrine system. J Neuroendocrinol 2008; 20: 743-751. (Pubitemid 351858726)
95. Ninan I., Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex. J Neurochem 2011; 119: 324-331.
96. Sarnyai Z, Szabo G, Kovacs GL, Telegdy G., Oxytocin attenuates the cocaine-induced exploratory hyperactivity in mice. Neuroreport 1990; 1: 200-202.
97. Drago F, Caldwell JD, Pedersen CA, Continella G, Scapagnini U, Prange AJ Jr., Dopamine neurotransmission in the nucleus accumbens may be involved in oxytocin-enhanced grooming behavior of the rat. Pharmacol Biochem Behav 1986; 24: 1185-1188. (Pubitemid 16067394)
98. Drago F, Contarino A, Busa L., The expression of neuropeptide-induced excessive grooming behavior in dopamine D1 and D2 receptor-deficient mice. Eur J Pharmacol 1999; 365: 125-131. (Pubitemid 29070756)
99. Liu Y, Wang ZX., Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles. Neuroscience 2003; 121: 537-544. (Pubitemid 38367494)
100. Kovacs G, Telegdy G., Effects of oxytocin, des-glycinamide-oxytocin and anti-oxytocin serum on the alpha-MPT-induced disappearance of catecholamines in the rat brain. Brain Res 1983; 268: 307-314. (Pubitemid 13096601)
101. Qi J, Yang JY, Song M, Li Y, Wang F, Wu CF., Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice. Naunyn Schmiedebergs Arch Pharmacol 2008; 376: 441-448.
102. Uvnas-Moberg K, Alster P, Svensson TH., Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats. Psychopharmacology (Berl) 1992; 109: 473-476.
103. Kiss A, Bundzikova J, Pirnik Z, Mikkelsen JD., Different antipsychotics elicit different effects on magnocellular oxytocinergic and vasopressinergic neurons as revealed by Fos immunohistochemistry. J Neurosci Res 2010; 88: 677-685.
104. Souza RP, Ismail P, Meltzer HY, Kennedy JL., Variants in the oxytocin gene and risk for schizophrenia. Schizophr Res 2010; 121: 279-280.
105. Feifel D, Reza T., Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating. Psychopharmacology 1999; 141: 93-98. (Pubitemid 29193300)
106. Caldwell HK, Stephens SL, Young WS III., Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice. Mol Psychiatry 2009; 14: 190-196.
107. Lee PR, Brady DL, Shapiro RA, Dorsa DM, Koenig JI., Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology 2005; 30: 1883-1894. (Pubitemid 41486413)
108. Sams-Dodd F., Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Rev Neurosci 1999; 10: 59-90. (Pubitemid 29396547)
109. Allen RM, Young SJ., Phencyclidine-induced psychosis. Am J Psychiatry 1978; 135: 1081-1084. (Pubitemid 8395441)
110. Lee PR, Brady DL, Shapiro RA, Dorsa DM, Koenig JI., Prenatal stress generates deficits in rat social behavior: reversal by oxytocin. Brain Res 2007; 1156: 152-167. (Pubitemid 46920515)
111. Brown AS., The environment and susceptibility to schizophrenia. Prog Neurobiol 2011; 93: 23-58.
112. Van Os J, Kenis G, Rutten BP., The environment and schizophrenia. Nature 2010; 468: 203-212.
113. Qi J, Yang JY, Wang F, Zhao YN, Song M, Wu CF., Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology 2009; 56: 856-865.
114. Meyer-Lindenberg A, Miletich RS, Kohn PD, et al., Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 2002; 5: 267-271. (Pubitemid 34171141)
115. Weinberger DR, Lipska BK., Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr Res 1995; 16: 87-110.
116. Feifel D, Shilling PD, Belcher A., The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating. Eur Neuropsychopharmacol 2011 (in press).
117. Feifel D, Shilling PD, Melendez G., Clozapine and PD149163 elevate prepulse inhibition in Brown Norway rats. Behav Neurosci 2011; 125: 268-272.
118. Carlsson A., Does dopamine play a role in schizophrenia? Psychol Med 1977; 7: 583-597. (Pubitemid 8232990)
119. Carlsson A, Carlsson ML., A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialog Clin Neurosci 2006; 8: 137-142.
120. Sarter M, Nelson CL, Bruno JP., Cortical cholinergic transmission and cortical information processing in schizophrenia. Schizophr Bull 2005; 31: 117-138. (Pubitemid 41214362)
121. Qiao H, Noda Y, Kamei H, et al., Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment. Neuroreport 2001; 12: 11-15. (Pubitemid 32099018)
122. Azorin JM, Spiegel R, Remington G, et al., A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. Am J Psychiatry 2001; 158: 1305-1313. (Pubitemid 32717707)
123. Davis JM, Chen N, Glick ID., A meta-analysis of the efficacy of second-generation antipsychotics. Archiv Gen Psychiatry 2003; 60: 553-564. (Pubitemid 36682312)
124. Lewis SW, Barnes TR, Davies L, et al., Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull 2006; 32: 715-723. (Pubitemid 44412859)
125. Souza RP, de Luca V, Meltzer HY, Lieberman JA, Kennedy JL., Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes. Int J Neuropsychopharmacol 2010; 13: 793-798.
126. Koenig JI, Elmer GI, Shepard PD, et al., Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav Brain Res 2005; 156: 251-261. (Pubitemid 39576065)
127. Huber D, Veinante P, Stoop R., Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 2005; 308: 245-248. (Pubitemid 40558858)
128. Viviani D, Charlet A, Van Den Burg E, et al., Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science 2011; 333: 104-107.
129. Adolphs R., How do we know the minds of others? Domain-specificity, simulation, and enactive social cognition. Brain Res 2006; 1079: 25-35.
130. Braff DL, Geyer MA, Swerdlow NR., Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001; 156: 234-258. (Pubitemid 32705488)
131. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR., Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 2001; 156: 117-154. (Pubitemid 32702206)
132. Koch M, Schnitzler HU., The acoustic startle response in rats -circuits mediating evocation, inhibition and potentiation. Behav Brain Res 1997; 89: 35-49. (Pubitemid 28062697)
133. Swerdlow NR, Geyer MA, Braff DL., Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 2001; 156: 194-215. (Pubitemid 32702213)
134. Geyer MA, Ellenbroek B., Animal behavior models of the mechanisms underlying antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 1071-1079. (Pubitemid 37464953)
135. Palmer AA, Dulawa SC, Mottiwala AA, Conti LH, Geyer MA, Printz MP., Prepulse startle deficit in the Brown Norway rat: a potential genetic model. Behav Neurosci 2000; 114: 374-388. (Pubitemid 30488997)
136. Ferguson JN, Aldag JM, Insel TR, Young LJ., Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci 2001; 21: 8278-8285. (Pubitemid 32952782)
137. Mantella RC, Vollmer RR, Li X, Amico JA., Female oxytocin-deficient mice display enhanced anxiety-related behavior. Endocrinology 2003; 144: 2291-2296. (Pubitemid 36629880)
138. Teltsh O, Kanyas-Sarner K, Rigbi A, Greenbaum L, Lerer B, Kohn Y., Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree. Int J Neuropsychopharmacol 2011.[E-pub ahead of print; DOI: 10.1017/S1461145711001374]
139. Feifel D, Shilling PD., Promise and pitfalls of animal models of schizophrenia. Curr Psychiatry Rep 2010; 12: 327-334.
140. Linkowski P, Geenen V, Kerkhofs M, Mendlewicz J, Legros JJ., Cerebrospinal fluid neurophysins in affective illness and in schizophrenia. Eur Arch Psychiatry Neurol Sci 1984; 234: 162-165. (Pubitemid 14020496)
141. Legros JJ, Gazzotti C, Carvelli T, et al., Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schi-zophrenics. Psychoneuroendocrinology 1992; 17: 611-617. (Pubitemid 23043123)
142. Beckmann H, Lang RE, Gattaz WF., Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. Psychoneuroendocrinology 1985; 10: 187-191. (Pubitemid 15071736)
143. Nussey SS, Hawthorn J, Page SR, Ang VT, Jenkins JS., Responses of plasma oxytocin and arginine vasopressin to nausea induced by apomorphine and ipecacuanha. Clin Endocrinol 1988; 28: 297-304. (Pubitemid 18079399)
144. Baskerville TA, Allard J, Wayman C, Douglas AJ., Dopamine-oxytocin interactions in penile erection. Eur J Neurosci 2009; 30: 2151-2164.
145. Melis MR, Argiolas A., Central control of penile erection: a re-visitation of the role of oxytocin and its interaction with dopamine and glutamic acid in male rats. Neurosci Biobehav Rev 2011; 35: 939-955.
146. Mai JK, Berger K, Sofroniew MV., Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia. Journal fur Hirnforschung 1993; 34: 133-154. (Pubitemid 23283183)
147. Glovinsky D, Kalogeras KT, Kirch DG, Suddath R, Wyatt RJ., Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication. Schizophr Res 1994; 11: 273-276. (Pubitemid 24063747)
148. Goldman MB, Gomes AM, Carter CS, Lee R., Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia. Psychopharmacology 2011; 216: 101-110.
149. Goldman MB, Wood G, Gavin M, et al., Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients. J Clin Endocrinol Metab 2007; 92: 698-704.
150. Goldman MB, Wang L, Wachi C, et al., Structural pathology underlying neuroendocrine dysfunction in schizo phrenia. Behav Brain Res 2011; 218: 106-113.
151. Keri S, Kiss I, Kelemen O., Sharing secrets: oxytocin and trust in schizophrenia. Soc Neurosci 2009; 4: 287-293.
152. Bartz JA, Zaki J, Bolger N, Ochsner KN., Social effects of oxytocin in humans: context and person matter. Trends Cogn Sci 2011; 15: 301-309.
153. Walker E, Mittal V, Tessner K., Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol 2008; 4: 189-216. (Pubitemid 351668616)
154. Averbeck BB, Bobin T, Evans S, Shergill SS., Emotion recognition and oxytocin in patients with schizophrenia. Psychol Med 2011. [E-pub ahead of print; DOI: 10.1017/S0033291711001413]
155. Mendrek A, Stip E., Sexual dimorphism in schizophrenia: is there a need for gender-based protocols? Expert RevNeurother 2011; 11: 951-959.
156. Figueira ML, Ouakinin S., Gender-related endocrinological dysfunction and mental disorders. Curr Opin Psychiatry 2010; 23: 369-372.
157. Murakami G, et al., Relationships among estrogen receptor, oxytocin and vasopressin gene expression and social interaction in male mice. Eur J Neurosci 2011; 34: 469-477.
158. Popeski N, et al., Prolactin and oxytocin interaction in the paraventricular and supraoptic nuclei: effects on oxytocin mRNA and nitric oxide synthase. J Neuroendocrinol 2003; 15: 687-696. (Pubitemid 36789968)
159. Gordon I, et al., Oxytocin and the development of parenting in humans. Biol Psychiatry 2010; 68: 377-382.
160. Holt-Lunstad J, Birmingham W, Light KC., The influence of depressive symptomatology and perceived stress on plasma and salivary oxytocin before, during and after a support enhancement intervention. Psychoneuroendocrinology 2011; 36: 1249-1256.
161. Bernstein HG, Stanarius A, Baumann B, et al., Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998; 83: 867-875. (Pubitemid 28068907)
162. Goldman MB, Torres IJ, Keedy S, Marlow-O'Connor M, Beenken B, Pilla R., Reduced anterior hippocampal formation volume in hyponatremic schizophrenic patients. Hippocampus 2007; 17: 554-562. (Pubitemid 47068264)
163. Pedersen C, Rau S, Salimi K, Gibson C, Leserman J, Penn D., Oxytocin treatment improves social cognition and reduces psychotic symptoms in schizophrenia (poster). Paper presented at the American College of Neuropsychopharmacology. 2010.
164. Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E., Oxytocin increases trust in humans. Nature 2005; 435: 673-676. (Pubitemid 40825511)
165. Zak PJ, Kurzban R, Matzner WT., Oxytocin is associated with human
166. Engell AD, Haxby JV, Todorov A., Implicit trustworthiness decisions: automatic coding of face properties in the human amygdala. J Cogn Neurosci 2007; 19: 1508-1519. (Pubitemid 47358153)
167. Koscik TR, Tranel D., The human amygdala is necessary for developing and expressing normal interpersonal trust. Neuropsychologia 2011; 49: 602-611.
168. Wizemann TM, Pardue ML., eds. Exploring biological contributions to human health: does sex matter? Washington, DC: National Academy Press, 2001.
169. Liedman R, Hansson SR, Howe D, et al., Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects. Gynecol Endocrinol 2008; 24: 508-513.
170. Salonia A, Nappi RE, Pontillo M, et al., Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women. Horm Behav 2005; 47: 164-169. (Pubitemid 40138829)
171. Shukovski L, Healy DL, Findlay JK., Circulating immunoreactive oxytocin during the human menstrual cycle comes from the pituitary and is estradiol dependent. J Clin Endocrinol Metab 1989; 68: 455-460. (Pubitemid 19052892)
172. Stock S, Bremme K, Uvnas-Moberg K., Plasma levels of oxytocin during the menstrual cycle, pregnancy and following treatment with HMG. Hum Reprod 1991; 6: 1056-1062.
173. Silber M, Almkvist O, Larsson B, Stock S, Uvnas-Moberg K., The effect of oral contraceptive pills on levels of oxytocin in plasma and on cognitive functions. Contraception 1987; 36: 641-650. (Pubitemid 18065765)
174. Stock S, Karlsson R, von Schoultz B., Serum profiles of oxytocin during oral contraceptive treatment. Gynecol Endocrinol 1994; 8: 121-126. (Pubitemid 24194261)
175. Bergemann N, Parzer P, Runnebaum B, Resch F, Mundt C., Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia. Psychol Med 2007; 37: 1427-1436. (Pubitemid 47581417)
176. Van Anders SM, Goldey KL, Kuo PX., The steroid/ peptide theory of social bonds: integrating testosterone and peptide responses for classifying social behavioral contexts. Psychoneuroendocrinology 2011; 36: 1265-1275.
177. Tandon R, Keshavan MS, Nasrallah HA., Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 2008; 102: 1-18.
178. Grewen KM, Girdler SS, Amico J, Light KC., Effects of partner support on resting oxytocin, cortisol, norepinephrine, and blood pressure before and after warm partner contact. Psychosom Med 2005; 67: 531-538. (Pubitemid 41033580)
179. Taylor SE, Klein LC, Lewis BP, Gruenewald TL, Gurung RA, Updegraff JA., Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight. Psychol Rev 2000; 107: 411-429.
180. Bakharev VD, Tikhomirov SM, Lozhkina TK., Psychotropic properties of oxytocin. Neurosci Behav Physiol 1986; 16: 160-164.
181. Calder A, et al., Facial emotion recognition after bilateral amygdala damage: differentially severe impairment of fear. Cogn Neuropsychol 1996; 13: 699-745. (Pubitemid 126463641)
182. Bruins J, Hijman R, Van Ree JM., Effect of a single dose of des-glycinamide-[Arg8]vasopressin or oxytocin on cognitive processes in young healthy subjects. Peptides 1992; 13: 461-468.
183. Fehm-Wolfsdorf G, Born J, Voigt KH, Fehm HL., Human memory and neurohypophyseal hormones: opposite effects of vasopressin and oxytocin. Psychoneuroendocrinology 1984; 9: 285-292. (Pubitemid 14071062)
184. Feifel D, Cobb P, MacDonald K, Nguyen A, Minassian A, Perry W., Daily intranasal oxytocin improves verbal memory in schizophrenia patients (poster). Paper presented at the American College of Neuropsychopharmacology. 2010.
185. Macdonald K, Macdonald TM., The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv Rev Psychiatry 2010; 18: 1-21.
186. Tremeau F., A review of emotion deficits in schizophrenia. Dialogues Clin Neurosci 2006; 8: 59-70.
187. Fett AK, Viechtbauer W, Dominguez MD, Penn DL, Van Os J, Krabbendam L., The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev 2011; 35: 573-588.
188. Penn DL., Keefe RS, Davis SM, Meyer PS, Perkins DO, Losardo D, et al., The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial. Schizophrenia research 2009; 115: 17-23.
189. Ursu S, Kring AM, Gard MG, et al., Prefrontal cortical deficits and impaired cognition-emotion interactions in schizophrenia. Am J Psychiatry 2011; 168: 276-285.
190. Macdonald E, Dadds MR, Brennan JL, Williams K, Levy F, Cauchi AJ., A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology 2011; 36: 1114-1126.
191. Ohlsson B, Truedsson M, Bengtsson M, et al., Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial. Neurogastroenterol Motil 2005; 17: 697-704. (Pubitemid 41400718)
192. Rummel-Kluge C, Komossa K, Schwarz S, et al., Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res 2010; 123: 225-233.
193. Rasmussen MS, Simonsen JA, Sandgaard NC, Hoilund-Carlsen PF, Bie P., Effects of oxytocin in normal man during low and high sodium diets. Acta Physiol Scand 2004; 181: 247-257. (Pubitemid 38822664)
194. Kubzansky LD, Mendes WB, Appleton A, Block J, Adler GK., Protocol for an experimental investigation of the roles of oxytocin and social support in neuroendocrine, cardiovascular, and subjective responses to stress across age and gender. BMC Public Health 2009; 9: 481.
195. Bryant RA, Hung L, Guastella AJ, Mitchell PB., Oxytocin as a moderator of hypnotizability. Psychoneuroendocrinology 2011 (in press).
196. Roberts DL, Penn DL., Social cognition and interaction training (SCIT) for outpatients with schizophrenia: a preliminary study. Psychiatry Res 2009; 166: 141-147.
197. Ceanga M, Spataru A, Zagrean AM., Oxytocin is neuroprotective against oxygen-glucose deprivation and reoxygenation in immature hippocampal cultures. Neurosci Lett 2010; 477: 15-18.
198. Cohen H, Kaplan Z, Kozlovsky N, Gidron Y, Matar MA, Zohar J., Hippocampal microinfusion of oxytocin attenuates the behavioural response to stress by means of dynamic interplay with the glucocorticoid-catecholamine responses. J Neuroendocrinol 2010; 22: 889-904.
199. Leuner B, Caponiti JM, Gould E., Oxytocin stimulates adult neurogenesis even under conditions of stress and elevated glucocorticoids. Hippocampus 2011 (in press).
200. Tomizawa K, Iga N, Lu YF, et al., Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade. Nat Neurosci 2003; 6: 384-390. (Pubitemid 36373984)
201. Windle RJ, Kershaw YM, Shanks N, Wood SA, Lightman SL, Ingram CD., Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J Neurosci 2004; 24: 2974-2982. (Pubitemid 38405745)